Most Read Articles
26 Aug 2017
Elderly individuals with high levels of serum uric acid may be at an increased risk of dementia, particularly vascular or mixed dementia, a study suggests.
14 Jan 2016
Tocotrienols are one of the two classes of compounds generally known as vitamin E. Prominent researcher in pharmaceutical technology, Professor Yuen Kah Hay, recently spoke to MIMS Doctor about the neuroprotective benefits conferred by palm tocotrienols. He shared key insights from a clinical trial performed by his team and about the compound’s potential for clinical use.
Elvira Manzano, 01 Feb 2014

There is no benefit to using ibuprofen over paracetamol in most patients with upper respiratory tract infections (URTIs). Steam inhalation therapy also does not offer any advantage, research has shown.

Dr. Joseph Delano Fule Robles, 01 Mar 2017

The tau and Aβ amyloid pathways have emerged as possible novel targets in treating Alzheimer’s disease (AD), according to studies discussed at the recently concluded Hong Kong Pharmacy Conference.

Thymectomy, hospitalization up risk of adverse events after surgery in myasthenia gravis

07 Jul 2017
Surgeons were alleged to have permanently disabled a kidney cancer patient by removing his healthy kidney instead of the affected organ.

Myasthenia gravis patients requiring hospitalization, emergency care and thymectomy appear to be at higher risks of adverse events following major surgery, a new nationwide matched cohort study reveals.

Medical and clinical information of 2,290 myasthenia gravis patients who underwent major surgery were retrieved from Taiwan’s National Health Insurance Research Database. A randomly selected control group (n=22,900) matched by propensity score was also established.

The primary outcome of the study was 30-day in-hospital mortality following surgery. Major complications such as pneumonia, septicaemia, stroke, bleeding, wound infection, acute myocardial infarction, acute renal failure and pulmonary embolism were assessed as secondary endpoints.

There was a higher overall risk of complications after surgery in patients with myasthenia gravis than in those without the neuromuscular disease (odds ratio [OR], 1.70; 95 percent CI, 1.44 o 2.00). Specifically, the risk of pneumonia (OR, 2.09; 1.65 to 2.65), septicaemia (OR, 1.31; 1.05 to 1.64) and bleeding (OR, 1.71; 1.07 to 2.72) were higher in myasthenia gravis patients.

The increased risk of postoperative complications was significant regardless of age group in both males (OR, 1.53; 1.18 to 1.97) and females (OR, 1.86; 1.50 to 2.31). Those without pre-existing medical conditions (OR, 2.15; 1.67 to 2.78) and with more than two conditions (OR, 1.56; 1.13 to 2.16) also have higher risks of postoperative complications.

Myasthenia gravis patients who received emergency care prior to operation (OR, 2.89; 1.99 to 4.21), thymectomy (OR, 3.71; 1.23 to 11.2) and who had been hospitalized (OR, 2.79; 2.20 to 3.52) also had increased risks of postoperative complications.

Low-income patients with myasthenia gravis (OR, 5.98; 3.12 to 11.5) had the highest risk of postoperative adverse events.

Editor's Recommendations
Most Read Articles
26 Aug 2017
Elderly individuals with high levels of serum uric acid may be at an increased risk of dementia, particularly vascular or mixed dementia, a study suggests.
14 Jan 2016
Tocotrienols are one of the two classes of compounds generally known as vitamin E. Prominent researcher in pharmaceutical technology, Professor Yuen Kah Hay, recently spoke to MIMS Doctor about the neuroprotective benefits conferred by palm tocotrienols. He shared key insights from a clinical trial performed by his team and about the compound’s potential for clinical use.
Elvira Manzano, 01 Feb 2014

There is no benefit to using ibuprofen over paracetamol in most patients with upper respiratory tract infections (URTIs). Steam inhalation therapy also does not offer any advantage, research has shown.

Dr. Joseph Delano Fule Robles, 01 Mar 2017

The tau and Aβ amyloid pathways have emerged as possible novel targets in treating Alzheimer’s disease (AD), according to studies discussed at the recently concluded Hong Kong Pharmacy Conference.